Jan 14, 2021 / 02:10PM GMT
James Daniel Gordon - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, and good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today at the JPMorgan Healthcare Conference, it's my pleasure to introduce Onno van de Stolpe, CEO of Galapagos for this presentation. So we're going to have a 20-minute presentation from Onno, and then we're going to have 20 minutes for your questions. And we're going to be joined by the Board of Galapagos management team. We've got the whole gang. So look forward to that. And you can immediately start registering your questions and the way you do this is with the Q&A function that's associated with this presentation on the conference website. And then I'm going to be reading your questions on the presentation from there.
So with that said, I'd like to welcome Onno and Galapagos at the conference, and I look forward to the presentation.
Onno Van De Stolpe - Galapagos NV - Co-Founder, Chairman of the Management Board, MD & CEO
Thank you, James. It's a pleasure to
Galapagos NV at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
